abstract |
(57) [Summary]nDisclosed are pharmaceutical compositions and methods for preventing or treating a number of amyloid diseases, including Alzheimer's disease, prion diseases, familial amyloid neuropathy, and the like. The pharmaceutical composition comprises an immunologically reactive amount of an amyloid fibril component, especially a fibril forming peptide or protein. Therapeutic compositions and methods using immunoreagents that react with such fibril components are also disclosed. |